Vesicular signalling and immune modulation as hedonic fingerprints: Proteomic profiling in the chronic mild stress depression model

Journal of Psychopharmacology

Volumn 26, Issue 12, 2012, Pages 1569-1583

  Bisgaard, Christina F ^a,e   Bak, Steffen ^b,c   Christensen, Trine ^a   Jensen, Ole N ^b   Enghild, Jan J ^d   Wiborg, Ove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e Department of Psychiatric Demography   (Denmark)

Author keywords

causality; chronic mild stress; depression; Dynamin 1; granular cell layer; hedonic fingerprinting; hippocampus; immune system proteins; post translational modification; protein profiling; Proteomics; S transferase omega 1; vesicular signalling

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; DYNAMIN I; ESCITALOPRAM; GLUTATHIONE S TRANSFERASE OMEGA 1; PEROXIREDOXIN 6; RAB GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; SERTRALINE; SYNTAXIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CHRONIC DISEASE; CHRONIC MILD STRESS; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; DRUG RESPONSE; ENZYME ACTIVITY; GRANULAR CELL; HIPPOCAMPUS; IMMUNOMODULATION; LASER CAPTURE MICRODISSECTION; MALE; MORNING DOSAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANHEDONIA; ANIMALS; CITALOPRAM; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IMMUNE SYSTEM; LASER CAPTURE MICRODISSECTION; MALE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TANDEM MASS SPECTROMETRY; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84870397541     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112460110     Document Type: Article

References (71)

1. Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics. 2003 ; 3: 36-44
2. Ambruso DR, Ellison MA, Thurman GW, et al. Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity. Biochim Biophys Acta. 2012 ; 1823: 306-315
3. Antonioli M, Rybka J, Carvalho LA. Neuroimmune endocrine effects of antidepressants. Neuropsychiatric Dis Treat. 2012 ; 8: 65-83
4. Banasr M, Chowdhury GM, Terwilliger R, et al. Glial pathology in an animal model of depression: Reversal of stress-induced cellular, metabolic and behavioural deficits by the glutamate-modulating drug riluzole. Molec Psychiatry. 2010 ; 15: 501-511
5. Banasr M, Soumier A, Hery M, et al. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry. 2006 ; 59: 1087-1096
6. Bannerman DM, Rawlins JNP, McHugh SB, et al. Regional dissociations within the hippocampus - memory and anxiety. Neurosci Biobehav Rev. 2004 ; 28: 273-283
7. Beasley CL, Pennington K, Behan A, et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics. 2006 ; 6: 3414-3425
8. Bergstrom A, Jayatissa MN, Mork A, et al. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res. 2008 ; 1196: 41-52
9. Bergstrom A, Jayatissa MN, Thykjaer T, et al. Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: A gene expression study. J Molec Neurosci. 2007 ; 33: 201-215
10. Berman RM, Narasimhan M, Charney DS. Treatment-refractory depression: Definitions and characteristics. Depress Anx. 1997 ; 5: 154-164
11. Bisgaard CF, Jayatissa MN, Enghild JJ, et al. Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J Molec Neurosci. 2007 ; 32: 132-144
12. Christensen T, Bisgaard CF, Nielsen HB, et al. Transcriptome differentiation along the dorso-ventral axis in laser-captured microdissected rat hippocampal granular cell layer. Neurosci. 2010 ; 170: 731-741
13. Christensen T, Bisgaard CF, Wiborg O. Biomarkers of anhedonic-like behaviour, antidepressant drug refraction, and stress resilience in a rat model of depression. Neurosci. 2011 ; 196: 66-79
14. Christiansen S, Bouzinova EV, Palme R, et al. Circadian activity of the hypothalamic-pituitary-adrenal axis is differentially affected in the rat chronic mild stress model of depression. Stress. 2012 ;:
15. Crisafulli C, Fabbri C, Porcelli S, et al. Pharmacogenetics of antidepressants. Frontiers Pharmacol. 2011 ; 2 :
16. Dale LB, Babwah AV, Ferguson SS. Mechanisms of metabotropic glutamate receptor desensitization: Role in the patterning of effector enzyme activation. Neurochem Int. 2002 ; 41: 319-326
17. Delgado y, Palacios R, Campo A, Henningsen K, et al. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry. 2011 ; 70: 449-457
18. Drugan RC, Christianson JP, Stine WW, et al. Swim stress-induced ultrasonic vocalizations forecast resilience in rats. Behav Brain Res. 2009 ; 202: 142-145
19. Duric V, Banasr M, Stockmeier CA, et al. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol. 2012 ;:
20. Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron. 2010 ; 65: 7-19
21. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003 ; 53: 649-659
22. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nature Rev Neurosci. 2009 ; 10: 446-457
23. Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nature Rev Molec Cell Biol. 2012 ; 13: 75-88
24. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Ann Int Med. 2011 ; 155: 772-785
25. Gil-Pisa I, E M-C, Ramos-Miguel A, et al. Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: Down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment. Internat J Neuropsychopharmacol. 2011 ; 15: 573-588
26. Grippo AJ, Francis J, Beltz TG, et al. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav. 2005 ; 84: 697-706
27. Haeffel GJ, Vargas I. Resilience to depressive symptoms: The buffering effects of enhancing cognitive style and positive life events. J Behav Ther Exp Psychiatry. 2011 ; 42: 13-18
28. Henningsen K, Andreasen JT, Bouzinova EV, et al. Cognitive deficits in the rat chronic mild stress model for depression: Relation to anhedonic-like responses. Behav Brain Res. 2009 ; 198: 136-141
29. Henningsen K, Palmfeldt J, Christiansen S, et al. hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression. Molec Cell Proteomics. 2012 ; 11 :
30. Hiemke C, Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Therapeut. 2000 ; 85: 11-28
31. Hjemdal O, Vogel PA, Solem S, et al. The relationship between resilience and levels of anxiety, depression, and obsessive-compulsive symptoms in adolescents. Clin Psychol Psychother. 2011 ; 18: 314-321
32. Holm MM, Nieto-Gonzalez JL, Vardya I, et al. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus. 2011 ; 21: 422-433
33. Ishizaki H, Miyoshi J, Kamiya H, et al. Role of rab GDP dissociation inhibitor alpha in regulating plasticity of hippocampal neurotransmission. Proc Nat Acad Sci USA. 2000 ; 97: 11587-11592
34. Jayatissa MN, Bisgaard C, Tingstrom A, et al. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacol. 2006 ; 31: 2395-2404
35. Jayatissa MN, Henningsen K, Nikolajsen G, et al. A reduced number of hippocampal granule cells does not associate with anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress. 2010 ; 13: 95-105
36. Jayatissa MN, Henningsen K, West MJ, et al. Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats. Brain Res. 2009 ; 1290: 133-141
37. Kapfhamer D, Valladares O, Sun Y, et al. Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nat Gen. 2002 ; 32: 290-295
38. Katz RJ, Baldrighi G. A further parametric study of imipramine in an animal model of depression. Pharmacol Biochem Behav. 1982 ; 16: 969-972
39. Kedracka-Krok S, Fic E, Jankowska U, et al. Effect of chronic mild stress and imipramine on the proteome of the rat dentate gyrus. J Neurochem. 2010 ; 113: 848-859
40. Kendler KS, Karlowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. 1999 ; 156: 837-841
41. Kim K, Kim S-H, Kim J, et al. Glutathione S-transferase omega 1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease. J Biol Chem. 2012 ; 287: 6628-6641
42. Laliberte RE, Perrgaux DG, Hoth LR, et al. Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1 posttranslational processing. J Biol Chem. 2003 ; 278: 16567-16578
43. Lamanda A, Zahn A, Roder D, et al. Improved Ruthenium II tris (bathophenantroline disulfonate) staining and destaining protocol for a better signal-to-background ratio and improved baseline resolution. Proteomics. 2004 ; 4: 599-608
44. Li YJ, Oliveira SA, Xu P, et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Molec Gen. 2003 ; 12: 3259-3267
45. Maes M, Fisar Z, Medina M, et al. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates - Nrf2 activators and GSK-3 inhibitors. Inflammopharmacol. 2011 ;:
46. Mairesse J, Vercoutter-Edouart AS, Marrocco J, et al. Proteomic characterization in the hippocampus of prenatally stressed rats. J Proteomics. 2012 ; 75: 1764-1770
47. Martins-De-Souza D, Dias-Neto E, Schmitt A, et al. Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry. 2010 ; 11: 110-120
48. Mi H, Dong Q, Muruganujan A, et al. PANTHER version 7: Improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Ac Res. 2010 ; 38: D204-210
49. Mineur YS, Belzung C, Crusio WE. Functional implications of decreases in neurogenesis following chronic mild stress in mice. Neurosci. 2007 ; 150: 251-259
50. Moreau JL, Scherschlicht R, Jenck F, et al. Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol. 1995 ; 6: 682-687
51. Moser MB, Moser EI. Functional differentiation in the hippocampus. Hippocampus. 1998 ; 8: 608-619
52. Ou JJ, Xun GL, Wu RR, et al. Efficacy and safety of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, randomized, double-blind, flexible-dose study. Psychopharmacol. 2011 ; 213: 639-646
53. Perkins DN, Pappin DJC, Creasy DM, et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999 ; 20: 3551-3567
54. Quitkin FM, Rabkin JG, Gerald J, et al. Validity of clinical trials of antidepressants. Am J Psychiatry. 2000 ; 157: 327-337
55. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacol. 2012 ; 62: 63-77
56. Schubert KO, Focking M, Prehn JH, et al. Hypothesis review: Are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?. Molec Psychiatry. 2011 ; 17: 669-681
57. Smillie KJ, Cousin MA. Dynamin I phosphorylation and the control of synaptic vesicle endocytosis. Biochem Soc Symposium. 2005 ;: 87-97
58. Snyder JS, Soumier A, Brewer M, et al. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011 ; 476: 458-461
59. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Molec Cell Biol. 2009 ; 10: 513-525
60. Strekalova T, Gorenkova N, Schunk E, et al. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol. 2006 ; 17: 271-287
61. Sudhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring Harbor Perspectives in Biology. 2011 ; 3: a005637
62. Sullivan B, Payne TW. Affective disorders and cognitive failures: A comparison of seasonal and nonseasonal depression. Am J Psychiatry. 2007 ; 164: 1663-1667
63. Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Ac Res. 2011 ; 39: D561-568
64. Ünlü M, Morgan ME, Minden JS. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis. 1997 ; 18: 2071-2077
65. Ventura D, Armstrong EP, Skrepnek GH, et al. Escitalopram versus sertraline in the treatment of major depressive disorder: A randomized clinical trial. Curr Med Res Op. 2007 ; 23: 245-250
66. Vialou V, Robison AJ, Laplant QC, et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nature Neurosci. 2010 ; 13: 745-752
67. Willner P. Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiol. 2005 ; 52: 90-110
68. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev. 1992 ; 16: 525-534
69. Wu L, Peng J, Wei C, et al. Characterization, using comparative proteomics, of differentially expressed proteins in the hippocampus of the mesial temporal lobe of epileptic rats following treatment with valproate. Amino Ac. 2011 ; 40: 221-238
70. Yazir Y, Utkan T, Aricioglu F. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Basic & Clinical Pharmacology & Toxicology. 2012 ; 111: 154-160
71. Zadrozna M, Nowak B, Lason-Tyburkiewicz M, et al. Different pattern of changes in calcium binding proteins immunoreactivity in the medial prefrontal cortex of rats exposed to stress models of depression. Pharmacol Rep. 2011 ; 63: 1539-1546